Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

PACKAGING PROGRESS UPDATE

3 Oct 2013 07:00

RNS Number : 6006P
Xaar PLC
03 October 2013
 



 

3 October 2013

 

 

Xaar plc

 

 

PACKAGING PROGRESS UPDATE

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the inkjet printing technology Group headquartered in Cambridge, is pleased to issue an update on recent progress made in developing new opportunities in the packaging sector.

 

Xaar's market leading technology is at the heart of multiple innovative digital inkjet packaging solutions which were launched or demonstrated by Xaar's OEM partners at major exhibitions during September 2013.

 

· At Print 13 (8-12th September, Chicago) FFEI Ltd, a leading developer, manufacturer and supplier of digital imaging solutions, launched its new-generation Graphium digital UV inkjet printer. The product will be distributed by Fujifilm in both the USA and Europe. Xaar 1001 printheads were specified by FFEI to deliver the high productivity, reliability and quality that customers require for label, packaging and speciality print applications.

 

· At DRINKTEC (16-20th September 2013, Munich) four of Xaar's partner OEMs publicly demonstrated for the first time innovative "direct-to-shape" digital printing solutions. The four OEMs demonstrated systems which enable full colour images and text to be digitally printed directly onto glass, PET and metal containers, creating significant efficiencies through reductions in materials and inventory, improving time to market and eliminating many of the costs associated with using labels or sleeves. In addition, this technology allows digital decoration of irregular-shaped and textured containers which can pose a challenge for traditional labels and sleeves. It is expected that these offerings will now undergo a number of field trials which, if successful, will lead to the commercialisation of the technology.

 

· At Labelexpo Europe (24-27th September 2013, Brussels), Xaar's partner OEMs including ALS Engineering, Durst, EFI Jetrion, FFEI/Fujifilm, INX International, JF Machines and Stork Prints, all demonstrated their latest Xaar 1001-enabled labelling solutions which range from stand-alone entry-level systems for late-stage overprinting, to fully integrated systems for in-line graphics digital printing and finishing.

 

For further detail on these and other developments please go to www.xaar.com/news.aspx to access Xaar's latest news releases.

 

Ian Dinwoodie, Xaar's Chief Executive, commented:

 

"It is pleasing to see the progress being made in this significant market. Digital print of full colour graphic labels is clearly gaining traction in the packaging industry as evidenced by the strength of our OEMs' product line-up recently exhibited. The first public 'direct-to-shape' demonstrations clearly created an industry buzz, and we look forward to our partners moving through their field trials and into commercialisation. Whilst this recent activity is not expected to have any material impact on Xaar's 2013 financial results, the positive feedback received reinforces the potential for Xaar's technology to create transformational and disruptive solutions across multiple discrete markets".

 

END

 

 

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

Alex Bevis, Finance Director

Bankside Consultants:

020-7367-8888

Simon Bloomfield

Fiona Scholes

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFSAESEFDSESS
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.